Navigation Links
Targeted cancer therapy kills prostate tumor cells
Date:6/6/2011

A new targeted therapy for prostate cancer halts tumor growth in animals with advanced prostate cancer that is resistant to hormone therapy, a new study finds. The results will be presented Saturday at The Endocrine Society's 93rd Annual Meeting in Boston.

"This targeted therapy may provide a treatment breakthrough that will extend the lives of men with advanced, hormone-refractory prostate cancer," said lead investigator Shuk-mei Ho, PhD, chairwoman of the Department of Environmental Health at the University of Cincinnati.

Men with prostate cancer that has recurred or has spread outside the prostate routinely receive androgen deprivation therapy, which blocks the action of the male hormones. This castration occurs through surgical removal of both testes or more often with medications. Although effective, this hormone-blocking treatment eventually stops working in some patients, Ho said.

"These patients are left with very few treatment options and usually succumb quickly to the disease," she said.

Ho's team previously found they can inhibit the growth of prostate cancer cell lines in culture by targeting and activating a protein called G protein-coupled receptor 30 (GPR30) using the experimental drug G-1, a GPR30 agonist, or stimulator.

In their new study, funded by the Veterans Affairs and the National Institutes of Health, Ho and her co-workers tested G-1 in an animal model of castration-resistant prostate cancer. They implanted human prostate cancer cells beneath the skin of male mice. The established tumor regressed upon castration and after the cancer relapsed, they injected the mice with a low dose of G-1. They also gave G-1 to noncastrated, or "intact," male mice that had prostate tumors. In these intact mice that still had male hormones, G-1 did not stop growth of the prostate tumors or cause substantial death of tumor cells (necrosis), they found.

"Surprisingly, G-1 was highly effective in halting
'/>"/>

Contact: Aaron Lohr
alohr@endo-society.org
240-482-1380
The Endocrine Society
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Targeted delivery of losartan reduces liver inflammation and scarring
2. Gene-Targeted Cancer Fix Could Be a Breakthrough
3. Survival in metastatic breast cancer patients is improving: targeted therapies have contributed
4. Targeted agent blocked growth of deadly brain cancer in preclinical studies
5. Kaiser Permanente Southern California to Offer FitOrbit Online Personal Training to Targeted Patients
6. New targeted therapy effective in treating advanced prostate cancer
7. Gene-Targeted Therapy Might Help Prevent Paralysis
8. Site Steering Launches Keyword Targeted Small Business Internet Video Advertising Program That Achieves First Page Search Results Within Days
9. Drug in new class of targeted therapies shows early promise against blood-related cancers
10. Women Smokers Targeted on World No Tobacco Day
11. Targeted immunotherapy shows promise for metastatic breast, pancreatic cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 28, 2014 Ticket Down is ... in Miami, FL at the Sun Life Stadium in ... football between Argentina and Brazil has is one that has ... more rivalries are forming on a consistent basis. The ... new height in the recent 2014 World Cup. To ...
(Date:7/28/2014)... 2014 (HealthDay News) --,The more chronic medical conditions people ... may be, a new study claims. Since ... issues, scientists at Johns Hopkins Bloomberg School of Public ... why gains in life expectancy are slowing in the ... as diabetes, kidney disease and heart failure is now ...
(Date:7/28/2014)... (HealthDay News) -- Endurance runners are far more likely ... condition, according to a new study. The ... in warm climates are actually 10 times more likely ... less common sudden death of a young and apparently ... an irregular heartbeat, often gets a lot more media ...
(Date:7/28/2014)... is enough oxygen present to support their offspring, but ... rule. Researchers at The Johns Hopkins University have now ... enabling cancers to continue to divide even without a ... that lysosomes the cell,s protein "recycling centers" ... evidence that certain drugs can halt the growth of ...
(Date:7/28/2014)... Parker Waichman LLP, a personal injury law ... the heroes of 9/11 are never forgotten, comments that the ... deadline. According to a VCF message dated July ... on or before October 12, 2012 must file a Registration ... others who were allegedly injured by the toxic dust cloud ...
Breaking Medicine News(10 mins):Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for Sept. 5th Showdown 2Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for Sept. 5th Showdown 3Health News:Chronic Medical Conditions Can Shorten Seniors' Lives: Study 2Health News:Heat Stroke a Greater Threat to Endurance Runners Than Heart Problems: Study 2Health News:Cell's recycling center implicated in division decisions 2Health News:October 12, 2014 Deadline Approaching for 9/11 First Responders Suffering from Certain Cancers to Submit Their Registration to the VCF, Parker Waichman LLP Comments 2Health News:October 12, 2014 Deadline Approaching for 9/11 First Responders Suffering from Certain Cancers to Submit Their Registration to the VCF, Parker Waichman LLP Comments 3
... a young Indian American is hard put to find a ... South Asians are listed in the US Bone Marrow registry. ... a disease known as Acute Myelogenous Leukemia (or AML), a ... Asian community has come together nationwide to help him and ...
... International Diabetes Federation (IDF) today called for projects that ... with diabetes and to implement practical solutions for improving ... as BRIDGES (Bringing Research in Diabetes to Global Environments ... Congress in Cape Town, South Africa and was officially ...
... ice sheet to break up, even though the air over ... at least a century, according to a new study ... ,As part of their study, the team led by ... how high the ice had deposited boulders in Antarctica's Framnes ...
... Echinacea, a medicinal herb that came to prominence thanks to its ... catching a cold, a wide-scale study has confirmed. ,Taking ... percent and may also shorten the duration of a cold almost ... Sunday in the July issue of the journal The Lancet Infectious ...
... studies have found that new adjuvant treatments for breast ... Published in the August 1, 2007 issue of Cancer, ... studies looked at the cost-effectiveness of different drugs for ... ,In a Canadian economic study of estrogen ...
... Six World Heritage sites, including Mount Everest, could be at ... experts and groups . ,Urging the United Nations ... the Climate Justice Programme have petitioned the global body to ... that have signed the UN World Heritage Convention have a ...
Cached Medicine News:Health News:South Asians Seek Bone Marrow for Young Indian American 2Health News:The International Diabetes Federation Launches US$ 10 Million Grant to Improve Diabetes Care 2Health News:The International Diabetes Federation Launches US$ 10 Million Grant to Improve Diabetes Care 3Health News:Sioux Herb Confirmed as Shield Against Colds 2Health News:New Adjuvant Breast Cancer Treatments Found Cost-effective 2Health News:Everest, Five Other World Heritage Sites Face Climate Change Risk 2
(Date:7/28/2014)... July 28, 2014   Stone & Magnanini ... off-label marketing and fraud claims between the United ... Inc. ("VSI").  The settlement covers fraud in connection ... endovenous laser ablation of varicose veins for unapproved ... with a history of representing whistleblowers in groundbreaking ...
(Date:7/28/2014)... NEW YORK , July 28, 2014 /PRNewswire/ ... report is available in its catalogue: ... http://www.reportlinker.com/p0207141/Portugal-Pharmaceuticals-and-Healthcare-Report-Q3-2014.html ... BMI View: Faster-than-expected economic growth last ... and pharmaceutical forecasts slightly upwards. As forecast previously, ...
(Date:7/28/2014)... Mass. , July 28, 2014  VigeneTech, ... the release of LEGENDplex™ Data Analysis Software, an ... from flow cytometers.  BioLegend develops and offers varieties ... flow cytometers. With the support of VigeneTech,s data ... and accurately analyzed and easily reported ...
Breaking Medicine Technology:Stone & Magnanini LLP Announces $520,000 Department of Justice False Claims Act Settlement With Vascular Solutions, Inc. 2Stone & Magnanini LLP Announces $520,000 Department of Justice False Claims Act Settlement With Vascular Solutions, Inc. 3Portugal Pharmaceuticals and Healthcare Report Q3 2014 2Portugal Pharmaceuticals and Healthcare Report Q3 2014 3Portugal Pharmaceuticals and Healthcare Report Q3 2014 4VigeneTech Releases New Powerful Software for Flow Cytometry Data Analysis 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: